• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

T2 映射在心脏淀粉样变性中的作用

The Role of T2 Mapping in Cardiac Amyloidosis.

作者信息

Grazzini Giulia, Pradella Silvia, Bani Rossella, Fornaciari Chiara, Cappelli Francesco, Perfetto Federico, Cozzi Diletta, Giovannelli Simona, Sica Giacomo, Miele Vittorio

机构信息

Department of Radiology, Careggi University Hospital, Largo Brambilla 3, 50134 Florence, Italy.

Regional Amyloid Center, Azienda Ospedaliero Universitaria Careggi, Largo Piero Palagi 1, 50134 Florence, Italy.

出版信息

Diagnostics (Basel). 2024 May 18;14(10):1048. doi: 10.3390/diagnostics14101048.

DOI:10.3390/diagnostics14101048
PMID:38786346
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11120592/
Abstract

Cardiac amyloidosis (CA) is an infiltrative cardiomyopathy divided into two types: light-chain (LA) and transthyretin (ATTR) CA. Cardiac magnetic resonance (CMR) has emerged as an important diagnostic tool in CA. While late gadolinium enhancement (LGE), T1 mapping and extracellular volume (ECV) have a consolidate role in the assessment of CA, T2 mapping has been less often evaluated. We aimed to test the value of T2 mapping in the evaluation of CA. This study recruited 70 patients with CA (51 ATTR, 19 AL). All the subjects underwent 1.5 T CMR with T1 and T2 mapping and cine and LGE imaging. Their QALE scores were evaluated. The myocardial T2 values were significantly ( < 0.001) increased in both types of CA compared to the controls. In the AL-CA group, increased T2 values were associated with a higher QALE score. The myocardial native T1 values and ECV were significantly ( < 0.001) higher in the CA patients than in the healthy subjects. Left ventricular (LV) mass, QALE score and ECV were higher in ATTR amyloidosis compared with AL amyloidosis, while the LV ejection fraction was lower ( < 0.001). These results support the concept of the presence of myocardial edema in CA. Therefore, a CMR evaluation including not only myocardial T1 imaging but also myocardial T2 imaging allows for more comprehensive tissue characterization in CA.

摘要

心脏淀粉样变性(CA)是一种浸润性心肌病,分为两种类型:轻链(LA)型和转甲状腺素蛋白(ATTR)型CA。心脏磁共振成像(CMR)已成为CA的一种重要诊断工具。虽然钆延迟强化(LGE)、T1 mapping和细胞外容积(ECV)在CA评估中具有重要作用,但T2 mapping的评估较少。我们旨在测试T2 mapping在CA评估中的价值。本研究招募了70例CA患者(51例ATTR型,19例AL型)。所有受试者均接受了1.5T的CMR检查,包括T1和T2 mapping以及电影成像和LGE成像。评估了他们的QALE评分。与对照组相比,两种类型的CA患者心肌T2值均显著升高(<0.001)。在AL-CA组中,T2值升高与更高的QALE评分相关。CA患者的心肌固有T1值和ECV显著高于健康受试者(<0.001)。与AL淀粉样变性相比,ATTR淀粉样变性患者的左心室(LV)质量、QALE评分和ECV更高,而LV射血分数更低(<0.001)。这些结果支持CA存在心肌水肿的概念。因此,CMR评估不仅包括心肌T1成像,还包括心肌T2成像,能够对CA进行更全面的组织特征分析。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/440c/11120592/267742385c7c/diagnostics-14-01048-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/440c/11120592/1cf0ade82826/diagnostics-14-01048-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/440c/11120592/e12c9b434c9e/diagnostics-14-01048-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/440c/11120592/ee3e0d48d2a8/diagnostics-14-01048-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/440c/11120592/7297c75e0120/diagnostics-14-01048-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/440c/11120592/74ce5c697429/diagnostics-14-01048-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/440c/11120592/267742385c7c/diagnostics-14-01048-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/440c/11120592/1cf0ade82826/diagnostics-14-01048-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/440c/11120592/e12c9b434c9e/diagnostics-14-01048-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/440c/11120592/ee3e0d48d2a8/diagnostics-14-01048-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/440c/11120592/7297c75e0120/diagnostics-14-01048-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/440c/11120592/74ce5c697429/diagnostics-14-01048-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/440c/11120592/267742385c7c/diagnostics-14-01048-g006.jpg

相似文献

1
The Role of T2 Mapping in Cardiac Amyloidosis.T2 映射在心脏淀粉样变性中的作用
Diagnostics (Basel). 2024 May 18;14(10):1048. doi: 10.3390/diagnostics14101048.
2
Myocardial native T2 measurement to differentiate light-chain and transthyretin cardiac amyloidosis and assess prognosis.心肌固有 T2 测量可区分轻链和转甲状腺素蛋白心脏淀粉样变性并评估预后。
J Cardiovasc Magn Reson. 2018 Aug 16;20(1):58. doi: 10.1186/s12968-018-0478-3.
3
The diagnostic value of multiparameter cardiovascular magnetic resonance for early detection of light-chain amyloidosis from hypertrophic cardiomyopathy patients.多参数心血管磁共振对肥厚型心肌病患者早期检测轻链淀粉样变性的诊断价值。
Front Cardiovasc Med. 2022 Oct 18;9:1017097. doi: 10.3389/fcvm.2022.1017097. eCollection 2022.
4
Diagnostic and Prognostic Value of Non-late Gadolinium Enhancement Cardiac Magnetic Resonance Parameters in Cardiac Amyloidosis.非延迟钆增强心脏磁共振参数在心脏淀粉样变性中的诊断和预后价值。
Curr Probl Cardiol. 2023 Apr;48(4):101573. doi: 10.1016/j.cpcardiol.2022.101573. Epub 2022 Dec 28.
5
The prognostic value of T1 mapping and late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with light chain amyloidosis.T1 mapping 和晚期钆增强心血管磁共振成像在轻链淀粉样变患者中的预后价值。
J Cardiovasc Magn Reson. 2018 Jan 3;20(1):2. doi: 10.1186/s12968-017-0419-6.
6
Tissue mapping by cardiac magnetic resonance imaging for the prognostication of cardiac amyloidosis: A systematic review and meta-analysis.心脏磁共振成像组织图谱对心脏淀粉样变性预后的评估:一项系统综述和荟萃分析
Int J Cardiol. 2024 May 15;403:131892. doi: 10.1016/j.ijcard.2024.131892. Epub 2024 Feb 19.
7
A compartment-based myocardial density approach helps to solve the native T1 vs. ECV paradox in cardiac amyloidosis.基于容积的心肌密度方法有助于解决心脏淀粉样变性中原发性 T1 与 ECV 悖论。
Sci Rep. 2022 Dec 16;12(1):21755. doi: 10.1038/s41598-022-26216-9.
8
Parametric mapping using cardiovascular magnetic resonance for the differentiation of light chain amyloidosis and transthyretin-related amyloidosis.应用心血管磁共振进行参数图分析以鉴别轻链淀粉样变性和转甲状腺素蛋白相关淀粉样变性。
Eur Heart J Cardiovasc Imaging. 2024 Sep 30;25(10):1451-1461. doi: 10.1093/ehjci/jeae154.
9
3.0T cardiac magnetic resonance quantification of native T1 and myocardial extracellular volume for the diagnosis of late gadolinium enhancement-negative cardiac amyloidosis.3.0T心脏磁共振对天然T1和心肌细胞外容积进行定量分析以诊断延迟钆增强阴性心脏淀粉样变性
Ann Transl Med. 2022 Jul;10(14):794. doi: 10.21037/atm-22-3251.
10
Diagnostic value of cardiovascular magnetic resonance in comparison to endomyocardial biopsy in cardiac amyloidosis: a multi-centre study.心血管磁共振诊断价值与心肌活检在心脏淀粉样变性中的比较:一项多中心研究。
Clin Res Cardiol. 2021 Apr;110(4):555-568. doi: 10.1007/s00392-020-01771-1. Epub 2020 Nov 10.

本文引用的文献

1
2023 ESC Guidelines for the management of cardiomyopathies.2023年欧洲心脏病学会心肌病管理指南。
Eur Heart J. 2023 Oct 1;44(37):3503-3626. doi: 10.1093/eurheartj/ehad194.
2
Clinical Impact of Cardiac MRI T1 and T2 Parametric Mapping in Patients with Suspected Cardiomyopathy.心脏磁共振成像T1和T2参数成像在疑似心肌病患者中的临床影响
Radiology. 2022 Nov;305(2):319-326. doi: 10.1148/radiol.220067. Epub 2022 Jul 5.
3
FLORA software: semi-automatic LGE-CMR analysis tool for cardiac lesions identification and characterization.
FLORA 软件:用于心脏病变识别和特征分析的半自动 LGE-CMR 分析工具。
Radiol Med. 2022 Jun;127(6):589-601. doi: 10.1007/s11547-022-01491-8. Epub 2022 Apr 18.
4
Cardiovascular magnetic resonance for suspected cardiac amyloidosis: where are we now?疑似心脏淀粉样变性的心血管磁共振:我们现在在哪里?
Heart Fail Rev. 2022 Sep;27(5):1543-1548. doi: 10.1007/s10741-022-10226-w. Epub 2022 Mar 4.
5
Diagnosis and treatment of cardiac amyloidosis. A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.心脏淀粉样变性的诊断与治疗。欧洲心脏病学会心肌和心包疾病工作组立场声明。
Eur J Heart Fail. 2021 Apr;23(4):512-526. doi: 10.1002/ejhf.2140. Epub 2021 Apr 7.
6
Mitral valve prolapse imaging: the role of tissue characterization.二尖瓣脱垂成像:组织特征的作用。
Quant Imaging Med Surg. 2020 Dec;10(12):2396-2400. doi: 10.21037/qims-2020-25.
7
Cardiac magnetic resonance in hypertrophic and dilated cardiomyopathies.肥厚型和扩张型心肌病的心脏磁共振成像。
Radiol Med. 2020 Nov;125(11):1056-1071. doi: 10.1007/s11547-020-01276-x. Epub 2020 Sep 18.
8
Myocardial native T2 measurement to differentiate light-chain and transthyretin cardiac amyloidosis and assess prognosis.心肌固有 T2 测量可区分轻链和转甲状腺素蛋白心脏淀粉样变性并评估预后。
J Cardiovasc Magn Reson. 2018 Aug 16;20(1):58. doi: 10.1186/s12968-018-0478-3.
9
Cardiac magnetic resonance in patients with mitral valve prolapse: Focus on late gadolinium enhancement and T1 mapping.心脏磁共振成像在二尖瓣脱垂患者中的应用:关注晚期钆增强和 T1 mapping。
Eur Radiol. 2019 Mar;29(3):1546-1554. doi: 10.1007/s00330-018-5634-5. Epub 2018 Aug 7.
10
Cardiovascular Magnetic Resonance in Cardiac Amyloidosis: T1 Is Not Enough.心脏淀粉样变性中的心血管磁共振成像:仅T1加权成像不够。
J Am Coll Cardiol. 2018 Jun 26;71(25):2932-2934. doi: 10.1016/j.jacc.2018.04.025.